About 18mg Recombinant Tissue Plasminogen Activator Injection Kit
Access the new, masterful solution for acute myocardial infarction and ischemic stroke with Cipla's 18mg Recombinant Tissue Plasminogen Activator Injection Kit. Featured for its noteworthy efficacy, this sought-after thrombolytic agent is a sterile, off-white lyophilized powder, included with reconstitution solvent for intravenous administration. Not only is it stable when refrigerated, but the product comes meticulously packaged for hospital use. This prescription-only biological product from India assures quality and reliability, offering a shelf life of two years and tailored dosage as recommended by physicians. Perfectly suited for adult patients with critical care needs.
Distinct Advantages and Multifaceted Application
18mg Recombinant Tissue Plasminogen Activator Injection Kit delivers rapid thrombolytic action, making it highly advantageous for urgent hospital scenarios. Its versatile application surface includes use in acute care settings, with media covering intravenous administration for myocardial infarction and ischemic stroke. This kit's reliable performance and sterile preparation ensure it meets the demanding standards medical professionals require when treating life-threatening conditions quickly and effectively.
Sample Availability and Premium Delivery Service
A sample of the 18mg Recombinant Tissue Plasminogen Activator Injection Kit is available for evaluation, demonstrating its top-tier formulation. Shipped from a premium FOB port in India, each kit undergoes quick dispatch to meet urgent hospital needs. The streamlined logistics result in rapid delivery times, ensuring healthcare providers have timely access to this essential medication when treating acute thrombotic events.
FAQ's of 18mg Recombinant Tissue Plasminogen Activator Injection Kit:
Q: How should the Recombinant Tissue Plasminogen Activator Injection Kit be stored?
A: The kit should be stored below 25C and remains stable when refrigerated to maintain its sterility and efficacy.
Q: What is the recommended administration route for this injection kit?
A: The injection is administered intravenously after proper reconstitution with the solvent provided in the kit.
Q: When is it appropriate to use this thrombolytic agent?
A: This product is indicated for the treatment of acute myocardial infarction and ischemic stroke, as prescribed by a physician.
Q: What advantages does this kit offer hospitals and medical professionals?
A: The kit provides a sterile, stable, and easy-to-reconstitute solution that ensures rapid thrombolytic action for critical care situations.
Q: Where is this product manufactured and supplied from?
A: The 18mg Recombinant Tissue Plasminogen Activator Injection Kit is manufactured and shipped from India, ensuring premium quality and reliable access.
Q: What is the process for preparing the injection for use?
A: Before administration, the lyophilized powder must be reconstituted with the solvent included in the kit, as per dosage guidelines.